Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

439
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
439

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transplantation of older DCD livers in the machine perfusion era: a U.S. cohort study.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Beyond second-line therapy: Strategic sequencing of systemic treatments in advanced hepatocellular carcinoma.

Hepatology (Baltimore, Md.)·2026
Same author

A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396].

Surgery·2026
Same author

External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver Disease.

Digestive diseases and sciences·2026
Same author

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.

Seminars in liver disease·2026
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
查看所有相关文章

相关实验视频

Updated: Mar 1, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

740

通过BCLC原则优化肝癌护理

Gemma Iserte1,2,3, Neus Llarch1,2,3,4, Andrew M Moon5,6

  • 1Liver Oncology Unit, Liver Unit, Hospital Clínic, Barcelona, Spain.

Seminars in liver disease
|February 27, 2026
PubMed
概括
此摘要是机器生成的。

高级实践护士通过以价值为基础的协调和技术来增强肝细胞癌 (HCC) 护理. 这种以患者为中心的方法改善了结果,并赋予巴塞罗那诊所肝癌 (BCLC) 系统中的护士和患者权力.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.7K

相关实验视频

Last Updated: Mar 1, 2026

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

740
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.7K

科学领域:

  • 在瘤学瘤学.
  • 医疗保健管理的管理
  • 护理科学 护理科学

背景情况:

  • 肝细胞癌 (HCC) 护理正在经历显著的转变.
  • 正在采用创新策略来改善患者的治疗结果和生活质量.

研究的目的:

  • 探索受企业创新启发的HCC护理方面的进步,重点关注巴塞罗那诊所肝癌 (BCLC) 系统.
  • 突出高级实践护士 (APN) 在以患者为中心的护理协调和赋权方面的作用.

主要方法:

  • 审查关键进展,包括共享决策,远程监控,远程医疗和多学科团队合作.
  • 对企业洞察的应用进行分析,例如来自Rita McGrath的洞察,用于医疗实践.

主要成果:

  • 基于价值的协调,动态安排和个性化护理的实施减少了效率低下.
  • 通过教育和指导赋予护士和患者权力,可以提高治疗的坚持和自主性.
  • 利用远程医疗和实时警报等技术优化了资源配置,减少了住院治疗.
  • BCLC模型为更广泛的医疗保健系统提供了可扩展和可复制的解决方案.

结论:

  • 在BCLC框架内,高级实践护士在领导HCC护理转型方面至关重要.
  • 以患者为中心的护理协调,技术整合和护士/患者赋权是改善HCC管理和结果的关键.